-
公开(公告)号:US20090192138A1
公开(公告)日:2009-07-30
申请号:US12158872
申请日:2006-12-20
申请人: Daniel Kaspar Baeschlin , David Edward Clark , Stephen John Dunsdon , Garry Fenton , Amanda Fillmore , Neil Victor Harris , Christopher Higgs , Christopher Antony Hurley , Sussie Lerche Krintel , Robert Edward Mackenzie , Nils Ostermann , Finton Sirockin , Jonathan Mark Sutton
发明人: Daniel Kaspar Baeschlin , David Edward Clark , Stephen John Dunsdon , Garry Fenton , Amanda Fillmore , Neil Victor Harris , Christopher Higgs , Christopher Antony Hurley , Sussie Lerche Krintel , Robert Edward Mackenzie , Nils Ostermann , Finton Sirockin , Jonathan Mark Sutton
IPC分类号: A61K31/397 , C07D487/02 , A61K31/496 , A61K31/519 , C07D243/08 , A61K31/551 , C07D413/14 , A61K31/5377 , C07D403/14 , A61K31/501 , A61P3/00 , A61P9/00 , A61P25/00 , A61P1/00 , A61P35/00
CPC分类号: C07D487/04
摘要: The invention provides novel deazaxanthine and deazahypoxanthine compounds. The compounds may be useful in the therapy of diseases and conditions in which dipeptidylpeptidase-IV (DPP-IV) is implicated.
摘要翻译: 本发明提供新颖的脱甲黄嘌呤和脱邻二黄嘌呤化合物。 该化合物可用于治疗涉及二肽基肽酶-IV(DPP-IV)的疾病和病症。